PATENT CLAIM ANALYSIS

Application Number: 16228130
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["558", "070000"]

Abstract:
Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

Claim (Index 3):
The cell-binding agent-drug conjugate of  claim 1 , wherein Drug is selected from the group consisting of tubulysins, calicheamicins, auristatins, maytansinoids, CC-1065 compounds, morpholinos doxorubicins, taxanes, cryptophycins, epothilones, and benzodiazepine dimers consisting of dimers of pyrrolobenzodiazepine, tomaymycin, indolinobenzodiazepines, imidazobenzothiadiazepines, and oxazolidinobenzodiazepines, siRNA or a combination thereof, and pharmaceutically acceptable salts, or acids of any of the above.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.1875
- Patent Class: 558.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14432073', '16228437', '16228310', '15118726', '13542126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8448373511823422
- 35 USC 102 Novelty (BERT): 0.6740676340111283
- Combined Prediction Score: 0.8277603794652209
- Mean Citation Score: 607.8427720000002
- Max Citation Score: 658.0060000000002
- Similarity Product: 620.9044620642662

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test